Skip to main content

Table 1 Previous reports of the patients resected metachronous liver metastasis of PDAC and survived more than 3 years

From: Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case report

No.

Author

Year

Age

Sex

Part

Initial Operaion

Histology

UICC stage

Number of liver metastasis

Recurrent Operation

Additional therapy after hepatectomy

Time to Recurrence (year)

Survival (year)

Status

1

Lemke J [13]

2011

48

F

unknown

unknown

unknown

IB

solitary

unknown

no

3

17

alive with relapse-free

2

IIDA [14]

2014

63

F

head

SSPPD

well

III

solitary

PH

no

1.9

6

alive with relapse-free

3

Fujisaki [15]

2015

62

M

head

PD

unknown

III

solitary

SH

AC (GEM+S-1)

0.8

3.2

dead with relapse in lymph node

4

Fujisaki [15]

2015

51

M

head

PD

unknown

unknown

solitary

PH

AC (S-1, FOLFIRINOX)+ RT

1.4

3.2

alive with relapse in lymph node

5

Omichi [16]

2015

68

F

body

DP

poorly

IIB

solitary

PH

no

1.5

5.4

alive with relapse-free

6

Present case

2020

51

M

head

PD

well

IIB

solitary

PH

AC (S-1)

8

12.1

alive with relapse-free

  1. PDAC pancreatic ductal adenocarcinoma, PD pancreatoduodenectomy, SSPPD stomach-preserving pancreatoduodenectomy, DP distal pancreatectomy, SH segment heptectomy, PH partial hepatecomy, Lap laparoscopic, AC adjuvant chemotherapy, RT radiotherapy